July 28 (UPI) -- Pfizer reported Thursday record-high sales of $27.7 billion for the second quarter, up 47% from the same period last year on the strength of its COVID-19 vaccine and antiviral drug Paxlovid.
The pharmaceutical company reported net income of $9.9 billion, a 78% increase from the second quarter of 2021.